Skip to main content
Emergent BioSolutions Inc. logo

Emergent BioSolutions Inc. — Investor Relations & Filings

Ticker · EBS ISIN · US29089Q1058 LEI · 549300YW6TUOX8BE5103 US Manufacturing
Open in API
Filings indexed 1,264 across all filing types
Latest filing 2014-11-10 Interim / Quarterly Rep…
Country US United States of America
Listing US EBS

About Emergent BioSolutions Inc.

https://emergentbiosolutions.com/

Emergent BioSolutions Inc. is a life sciences company specializing in solutions for public health threats. The company develops, manufactures, and delivers medical countermeasures for national security and public health preparedness, addressing threats such as anthrax, smallpox, botulism, and Ebola. In addition to its biodefense portfolio, Emergent provides commercial products for endemic health crises, notably the opioid epidemic. The company also offers contract development and manufacturing services through strategic partnerships, leveraging its specialized capabilities to support biopharmaceutical innovators, governments, and non-governmental organizations.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2014
Interim / Quarterly Report 9M 2014
2014-11-10 English
Earnings Release 2014
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events. The text specifically mentions Item 2.02 "Results of Operations and Financial Condition" and states that the company announced financial and operating results for the period ended September 30, 2014. It also references a press release attached as Exhibit 99. The document itself is short (2379 characters) and primarily serves as an announcement of the earnings release rather than containing detailed financial statements or analysis. According to the rules, such a document is classified as an Earnings Release (ER) because it announces quarterly/periodical financial results with key highlights only, and is not a full interim or annual report. The presence of a press release attached further supports this classification. Therefore, the filing type is ER with high confidence.
2014-11-06 English
Regulatory Filings 2014
Regulatory Filings
2014-11-05 English
Regulatory Filings 2014
Regulatory Filings
2014-11-05 English
FORM 4
Director's Dealing
2014-10-16 English
FORM 4
Director's Dealing
2014-10-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.